联邦起诉前Zynex高管涉大规模医疗技术计费欺诈案
Feds charge former Zynex execs in massive medtech billing fraud case
生物技术与制药领域的最新动态
Feds charge former Zynex execs in massive medtech billing fraud case
Guardant Health gets FDA nod to expand use of blood test for colon cancer
AstraZeneca keeps UK research site on pause, but options open
Fortitude has faith molecular glue degraders can overcome ADC resistance
Genyro licences DNA builder from Caltech; Dizal targets Hong Kong listing
Biggest gainers and losers for Jan. 19-23, 2026
Biotech investor Cormorant secures $150M for another SPAC deal
Express Scripts considering settlement in FTC insulin price lawsuit
The formula for biotech success in 2026: Confidence, resilience and funding
Waters Corporation: How a Quiet Lab Workhorse Became a Strategic Tech Platform - AD HOC NEWS
Biopharma layoffs surged last year, but 2026 is a chance to turn the page
ROCK inhibitors disclosed in Avicenna Biosciences patents
US Dept. of HHS synthesizes new dopamine D2 antagonists
Helmholtz Zentrum Fur Infektionsforschung identifies new argyrin derivatives
Hetero Labs divulges EGFR inhibitors
Illumina price driven lower by pivotal resistance - Forecast today - 26-01-2026 - Economies.com
Lbp Am Sa Has $131.19 Million Holdings in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Comparator Drug Sourcing Global Market Review 2021-2025 and Forecast 2026-2031 Featuring Clinigen, BAP Pharma Group, Thermo Fisher Scientific, Laboratory Corporation of America, Catalent and More - Yahoo Finance Singapore
UK medicines agency seized 20M illegal drugs last year, including GLP-1s
Genmab halts enrollment for cancer drug from ProfoundBio buyout